跳至主要内容
临床试验/NCT04646174
NCT04646174已完成不适用

Addressing Psychological Risk Factors Underlying Smoking Persistence: The Fresh Start-II Study

Rush University Medical Center1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2020年12月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
66
试验地点
1
主要终点
Two-Week Smoking Abstinence

研究概览

简要总结

Chronic Obstructive Pulmonary Disease (COPD) is caused primarily by smoking and smoking cessation is the first-line treatment for slowing disease progression. Despite this, nearly 50% of COPD patients continue to smoke following diagnosis. Smokers with COPD report high rates of co-occurring conditions - nicotine dependence, depression, and anxiety - which serve as barriers to quitting. The current study will pilot test a behavioral intervention designed to target the common psychological factors underlying these co-occurring conditions and foster smoking cessation among COPD patients.

详细描述

Chronic Obstructive Pulmonary Disease (COPD) is caused primarily by smoking and smoking cessation is the first-line treatment for slowing disease progression. Despite this, nearly 50% of COPD patients continue to smoke following diagnosis. Smokers with COPD report high rates of co-occurring conditions - nicotine dependence, depression, and anxiety - which serve as barriers to quitting. The proposed research will develop and pilot test a behavioral intervention designed to target the common psychological factors underlying these co-occurring conditions and foster smoking cessation among COPD patients. The specific aim is to:

Aim: Examine effects of psychological risk factor reduction on smoking outcome. We will conduct a pilot trial in which 62 participants are randomized to the multi-component behavioral treatment (9 weekly sessions) or self-guided treatment (mailing of printed self-help materials).The primary outcome is number of days abstinent for 2 weeks post-quit (range = 0-14 days).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Eligible participants will be males and females who are:
  • •Diagnosed with COPD (as documented in electronic health record [EHR]),
  • •Daily cigarette smokers (5 or more cigarettes per day over past 30 days),
  • •Intend to quit smoking within the next 60 days,
  • •Report at least moderate level of smoking for affective regulation (SMQ-R coping subscale score 30 or greater),
  • •Have access to a smart phone, tablet, or computer, and
  • •Are able to communicate fluently in English

排除标准

  • •Any concurrent medical or psychiatric condition which would preclude ability to provide informed consent or perform study procedures (e.g., moderate to severe dementia and/or severe, uncontrolled schizophrenia), as determined by the treating physician or study PI.

研究组 & 干预措施

Multi-component Behavioral Treatment

Experimental

This treatment consists of nine weekly phone-based individual treatment sessions, 45-60 minutes each, delivered by a trained study therapist.

干预措施: Unified Protocol adapted for smoking cessation (Behavioral)

Multi-component Behavioral Treatment

Experimental

This treatment consists of nine weekly phone-based individual treatment sessions, 45-60 minutes each, delivered by a trained study therapist.

干预措施: American Lung Association self-management strategies for smoking cessation (Behavioral)

Self-guided Treatment

Experimental

This treatment consists of self-help materials from the American Lung Association that address evidence-based smoking cessation and self-management strategies.

干预措施: American Lung Association self-management strategies for smoking cessation (Behavioral)

结局指标

主要结局

Two-Week Smoking Abstinence

时间窗: 14 days post-quit date

Number of days abstinent for 2 weeks post-quit, as verified by CO \< 5 ppm

次要结局

  • Smoking Status(3 months post-quit)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验